United Kingdom

Showing 11-20 of 36 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Biological Signature of Diabetes Mellitus	University of Cambridge	Kourosh Saeb-Parsy	Cures	01-August-2023 to 31-July-2026	$514,959.00
Home-based measures of beta-cell function and CGM metrics to predict progression of pre-symptomatic individuals	University of Cambridge	M. Loredana Marcovecchio	Cures	01-October-2024 to 30-September-2027	$855,740.85
Profiling The Kinome In Type 1 Diabetes; Identifying Novel Targets For Biomarker Development and Disease-modifying Therapies	University of Bristol	Anna Long	Cures	01-April-2025 to 30-September-2026	$197,076.23
Pancreatic function; unanticipated insights into progression rate to type 1 diabetes	University of Bristol	Kathleen Gillespie	Cures	01-September-2024 to 31-August-2027	$545,259.92
The L selectin pathway in type 1 diabetes	University of Bristol	Kathleen Gillespie	Cures	01-September-2024 to 31-August-2027	$827,321.85
Progressing 4 antibody multiplex Lateral flow assay for Diabetes (Diabetes 4ward)	University of Birmingham	Alex Richter	Cures	01-August-2024 to 31-July-2026	$705,592.01
Can dysregulated immunity to bacterial lipopolysaccharide aid in identifying those at risk of developing Type 1 diabetes?	University of Birmingham	James Pearson	Cures	01-April-2026 to 31-March-2029	$667,691.00
Establishing the effectiveness, safety and acceptability of treatments to preserve beta cell function in people with type 1 diabetes (T1D)	University of Birmingham	Parth Narendran	Cures	01-September-2024 to 31-August-2027	$279,997.78
Genetic risk modelling and implementation of EarLy Surveillance for Autoimmune Diabetes (ELSA)	University of Birmingham	Parth Narendran	Cures	01-February-2026 to 31-January-2030	$653,050.94
Testing the feasibility and acceptability of EarLy Surveillance for Autoimmune diabetes: The ELSA Study	University of Birmingham	Parth Narendran	Cures	01-March-2022 to 31-August-2025	$585,569.82